MedPath

Gubra A/S

Gubra A/S logo
🇩🇰Denmark
Ownership
Public
Established
2008-01-01
Employees
219
Market Cap
-
Website
http://www.gubra.dk

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295

Phase 1
Recruiting
Conditions
Overweight
Healthy Volunteers
Interventions
Drug: GUB014295-PLACEBO
First Posted Date
2023-11-22
Last Posted Date
2025-05-09
Lead Sponsor
Gubra A/S
Target Recruit Count
124
Registration Number
NCT06144684
Locations
🇬🇧

Quotient Sciences, Nottingham, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.